Boon Industries Announces Effectiveness of Form 10 Registration Statement
Boon Industries Announces Effectiveness of Form 10 Registration Statement
The Company is now subject to the reporting requirements of the Securities Exchange Act of 1934
SACRAMENTO, CA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Boon Industries, Inc. (OTC PINK: BNOW) ("Boon" or the "Company"), an innovative bioscience company delivering solutions that benefit people and the planet, is pleased to announce today that its Form 10 Registration Statement filed with the U.S. Securities and Exchange Commission (the "SEC") became effective on February 14, 2022. As a result, the Company is now subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, and is required to file annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, and periodic reports on Form 8-K.
The Form 10 filing affords investors detailed information regarding the Company and its operations, including audited financial statements. This transparency should assist the investing public in making more informed investment decisions as they pertain to the Company's equity. The Form 10 can be reviewed in its entirety at www.sec.gov under the name of Boon Industries, Inc.
"We believe that the effectiveness of our Form 10 registration statement is a watershed event for Boon and its shareholders," stated Justin Gonzalez, Chairman & CEO, Boon Industries. "We sincerely appreciate the patience of our partners and investors as we move this company into an important new phase of expanded production and with the sunlight of transparency to record and celebrate our successes.
"Overall, this progress aligns with Boon's commitment to a new phase for the Company wherein we are pursuing new market opportunities and transparency simultaneously," added Gonzalez.
About Boon Industries
Boon Industries, Inc. (OTC:BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon's product offering is DiOx+™, a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind DiOx+ make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. DiOx+ helps protect agricultural crops from disease, is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon's CEO Justin Gonzalez. DiOx+ delivers on Boon's promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon's manufacturing facility and corporate headquarters in Grass Valley, California.
Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes", "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management's expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Please note that from time to time the Company may post new information at its website boonindustries.com, or via its current social media accounts below:
LinkedIn:
Twitter:
The Company's most current Investor Presentation is available at the following link:
Company Contact
Boon Industries, Inc.
Investor Relations & Financial Media
Integrity Media Inc.
team@integritymedia.com
Toll Free: (888) 216-3595
公司目前受1934年《證券交易法》的報告要求約束
加利福尼亞州薩克拉門託,2022年2月24日(環球社)NewMediaWire--消息Boon Industries,Inc.(場外交易PINK:BNOW)美國證券交易委員會是一家提供造福人類和地球的解決方案的創新型生物科學公司,該公司今天高興地宣佈,其提交給美國證券交易委員會的Form 10註冊聲明(以下簡稱“FORM 10註冊聲明”)於2022年2月14日生效。因此,本公司現須遵守經修訂的1934年《證券交易法》的報告要求,並須向美國證券交易委員會提交10-K表格的年度報告、10-Q表格的季度報告及8-K表格的定期報告。
Form 10檔案為投資者提供了有關該公司及其運營的詳細資訊,包括經審計的財務報表。這種透明度應該有助於投資公眾做出更明智的投資決定,因為這些決定與公司的股權有關。表格10可以在www.sec.gov上以Boon Industries,Inc.的名義進行完整審查。
Boon Industries董事長兼首席執行官賈斯汀·岡薩雷斯表示:“我們相信,我們Form 10註冊聲明的有效性對Boon及其股東來說是一個分水嶺。我們真誠地感謝我們的合作夥伴和投資者在我們將公司帶入擴大生產的重要新階段時所表現出的耐心,並在透明的陽光下記錄和慶祝我們的成功。
岡薩雷斯補充說:“總的來說,這一進展與Boon對公司新階段的承諾相一致,在這個階段,我們正在尋求新的市場機會和透明度。”
關於Boon Industries
Boon Industries,Inc.(場外交易代碼:BNOW)是一家創新的生物科學公司,提供造福人類和地球的解決方案。布恩公司產品的核心是二氧化氯消毒消毒器DIOX+™。二氧化氯已獲得OSHA、FDA、EPA和DOT的批准。DIOX+殺滅有害病原體,不會對使用者或環境產生危險的有毒物質。DIOX+背後的專利化學配方和工藝使其成為關鍵任務、高價值醫療設備以及實驗室和醫院環境中的空氣和表面消毒的理想選擇。Diox+有助於保護農作物免受疾病侵襲,用於水處理廠,並有助於降低倉儲、配送中心和電子商務支持設施的運營成本。在將Diox+引入美國市場之前,在Boon首席執行官賈斯汀·岡薩雷斯的推動下,二氧化氯在全球市場上使用了12年。Diox+兌現了Boon的承諾,在不犧牲健康和安全的情況下提供最有效、最實惠的解決方案。Diox+是在Boon位於加利福尼亞州草谷的製造工廠和公司總部生產的。
前瞻性陳述的避風港:本新聞稿包含非歷史事實的前瞻性陳述。前瞻性陳述包括描述公司未來計劃、目標或目標的估計和陳述,包括公司或管理層預期將出現的情況或結果的表述。前瞻性陳述可以用“相信”、“預期”、“預期”、“估計”、“可能”、“將”或“計劃”等術語來識別。由於前瞻性陳述以假設為基礎,涉及未來的事件和情況,因此它們本身就具有內在的風險和不確定性。雖然這些陳述是基於公司目前掌握的資訊,但公司不能保證實際結果將符合管理層的期望。前瞻性資訊涉及的風險、不確定性和其他因素可能導致實際事件、結果、業績、前景和機會與此類前瞻性資訊明示或暗示的情況大不相同。可能導致實際結果與這些前瞻性資訊大不相同的因素包括但不限於總體經濟和金融市場狀況的變化。儘管本公司認為在準備本新聞稿中的前瞻性資訊時使用的假設和因素是合理的,但不應過度依賴這些資訊,因為這些資訊僅適用於本新聞稿發佈之日,並且不能保證此類事件將在披露的時間框架內發生或根本不會發生。除法律要求外,公司沒有任何更新或修改任何前瞻性資訊的意圖或義務,無論是由於新資訊、未來事件或其他原因。
請注意,公司可能會不時在其網站上發佈新的資訊。Boonindustries.com,或通過其目前的社交媒體賬戶如下:
LinkedIn:是
推特:推特
該公司最新的投資者介紹可通過以下鏈接獲得:
公司聯繫人
福恩實業公司
投資者關係與財經媒體
誠信媒體公司。
郵箱:Team@IntegrityMedia.com
免費電話:(888)216-3595
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧